Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03410927
Title A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications

endometrial cancer

lung non-small cell carcinoma

gastroesophageal junction adenocarcinoma

transitional cell carcinoma

biliary tract cancer

breast cancer

Advanced Solid Tumor

colorectal cancer

stomach cancer

Therapies

TAS0728

Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
Winship Cancer Institute Atlanta Georgia 30322 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029-6504 United States Details
Sarah Cannon Nashville Tennessee 37203 United States Details
University of Texas - MD Anderson Houston Texas 77030 United States Details
Institut de Cancerologie Gustavo Roussy Paris 94800 France Details
Hospital Vall D'hebron Barcelona 8035 Spain Details
Sarah Cannon Research Institute - UK London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field